文献速递肺栓塞与肺血管病

SOX17缺陷介导肺动脉高压:性别、代谢与遗传的交汇点

SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

研究探讨SOX17缺陷在肺动脉高压(PAH)中的作用机制。在PAECs及慢性缺氧小鼠模型中,SOX17通过抑制HIF2α促进线粒体功能并减轻PAH;16αOHE通过下调SOX17介导PAH发展, linking性别二态性与SOX17遗传。

要点

  • SOX17在PAH组织中表达降低,条件性敲除加重缺氧性PH,过表达减轻。
  • SOX17通过抑制HIF2α促进PAECs氧化磷酸化和线粒体功能。
  • 16αOHE下调SOX17启动子活性,Sox17过表达减轻其加重的PH。

核心结论

  • SOX17通过抑制HIF2α促进线粒体生物能量学并减轻PAH。
  • 16αOHE通过下调SOX17介导PAH发展, linking性别二态性和SOX17遗传。

研究设计与样本

  • 使用PAECs的代谢(Seahorse)和启动子荧光素酶测定,结合慢性缺氧小鼠模型。
  • PAH患者调整分析纳入n=1,326。

主要发现

  • Sox17表达在PAH组织(啮齿动物模型和患者)中降低。
  • Tie2-Sox17条件性缺失(Sox17EC-/-)加重慢性缺氧性肺动脉高压,Tie2-Sox17过表达(Sox17Tg)减轻。
  • SOX17缺陷PAECs中代谢是受影响的首要通路;Sox17EC-/-小鼠肺中HIF2α浓度增加,Sox17Tg小鼠中减少。
  • 雄性大鼠肺Sox17表达高于雌性,提示雌激素信号抑制;Sox17Tg小鼠减轻16αOHE加重的慢性缺氧性肺动脉高压。
  • PAH患者中SOX17风险变异rs10103692与血浆柠檬酸盐浓度降低相关(n=1,326)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Genetic studies suggest that SOX17 (SRY-related HMG-box 17) deficiency increases pulmonary arterial hypertension (PAH) risk. Objectives: On the basis of pathological roles of estrogen and HIF2α (hypoxia-inducible factor 2α) signaling in pulmonary artery endothelial cells (PAECs), we hypothesized that SOX17 is a target of estrogen signaling that promotes mitochondrial function and attenuates PAH development via HIF2α inhibition. Methods: We used metabolic (Seahorse) and promoter luciferase assays in PAECs together with the chronic hypoxia murine model to test the hypothesis. Measurements and Main Results: Sox17 expression was reduced in PAH tissues (rodent models and from patients). Chronic hypoxic pulmonary hypertension was exacerbated by mice with conditional Tie2-Sox17 (Sox17EC-/-) deletion and attenuated by transgenic Tie2-Sox17 overexpression (Sox17Tg). On the basis of untargeted proteomics, metabolism was the top pathway altered by SOX17 deficiency in PAECs. Mechanistically, we found that HIF2α concentrations were increased in the lungs of Sox17EC-/- and reduced in those from Sox17Tg mice. Increased SOX17 promoted oxidative phosphorylation and mitochondrial function in PAECs, which were partly attenuated by HIF2α overexpression. Rat lungs in males displayed higher Sox17 expression versus females, suggesting repression by estrogen signaling. Supporting 16α-hydroxyestrone (16αOHE; a pathologic estrogen metabolite)-mediated repression of SOX17 promoter activity, Sox17Tg mice attenuated 16αOHE-mediated exacerbations of chronic hypoxic pulmonary hypertension. Finally, in adjusted analyses in patients with PAH, we report novel associations between a SOX17 risk variant, rs10103692, and reduced plasma citrate concentrations (n = 1,326). Conclusions: Cumulatively, SOX17 promotes mitochondrial bioenergetics and attenuates PAH, in part, via inhibition of HIF2α. 16αOHE mediates PAH development via downregulation of SOX17, linking sexual dimorphism and SOX17 genetics in PAH.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Sangam S, Sun X, Schwantes-An TH, et al. SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics. Am J Respir Crit Care Med. 2023. PMID: 36913491. doi:10.1164/rccm.202203-0450OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。